Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer

International Journal of Oncology

Volumn 47, Issue 3, 2015, Pages 1097-1102

  Nonaka, Ryoji ^a   Miyake, Yuichiro ^a   Hata, Taishi ^a   Kagawa, Yoshinori ^b   Kato, Takeshi ^b   Osawa, Hideki ^a   Nishimura, Junichi ^a   Ikenaga, Masakazu ^c   Murata, Kohei ^d   Uemura, Mamoru ^a   Okuzaki, Daisuke ^e   Takemasa, Ichiro ^a   Mizushima, Tsunekazu ^a   Yamamoto, Hirofumi ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI ROSAI HOSPITAL   (Japan)

^c OSAKA ROSAI HOSPITAL   (Japan)

^d Suita Municipal Hospital   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; MiR 103; MiR 720

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 21; MICRORNA 720; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN103 MICRORNA, HUMAN; MIRN720 MICRORNA, HUMAN;

ARTICLE; BLOOD EXAMINATION; BLOOD LEVEL; CANCER GRADING; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENDER; GENE EXPRESSION; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; VALIDATION STUDY; BLOOD; COLORECTAL NEOPLASMS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METASTASIS; PATHOLOGY; SEX DIFFERENCE; UPREGULATION;

BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEX FACTORS; UP-REGULATION;

EID: 84938095468     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3064     Document Type: Article

References (19)

1. Inoue Y and Kusunoki M: Advances and directions in chemotherapy using implantable port systems for colorectal cancer: A historical review. Surg Today 44: 1406-1414, 2014.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
3. Hewitson P, Glasziou P, Watson E, Towler B and Irwig L: Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): An update. Am J Gastroenterol 103: 1541-1549, 2008.
4. Ochiai H, Ohishi T, Osumi K, Tokuyama J, Urakami H, Seki S, Shimada A, Matsui A, Isobe Y, Murata Y, et al: Reevaluation of serum p53 antibody as a tumor marker in colorectal cancer patients. Surg Today 42: 164-168, 2012.
5. Mendell JT and Olson EN: MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187, 2012.
6. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
8. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
9. Fabbri M: miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn 10: 435-444, 2010.
10. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, Poon TC, Ng SS and Sung JJ: Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009.
11. Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J and Galandiuk S: Plasma miR-21: A potential diagnostic marker of colorectal cancer. Ann Surg 256: 544-551, 2012.
12. Nonaka R, Nishimura J, Kagawa Y, Osawa H, Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, et al: Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer. Oncol Rep 32: 2354-2358, 2014.
13. Toiyama Y, Takahashi M, Hur K, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105: 849-859, 2013.
14. Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, et al: miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 72: 3631-3641, 2012.
15. Wang X, Kuang Y, Shen X, Zhou H, Chen Y, Han Y, Yuan B, Zhou J, Zhao H, Zhi Q and Xue X: Evaluation of miR-720 prognostic significance in patients with colorectal cancer. Tumour Biol 36: 719-727, 2015.
16. Yang IP, Tsai HL, Huang CW, Huang MY, Hou MF, Juo SH and Wang JY: The functional significance of microRNA-29c in patients with colorectal cancer: A potential circulating biomarker for predicting early relapse. PLoS One 8: e66842, 2013.
17. Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED and Harris CC: Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer 130: 1378-1386, 2012.
18. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X, et al: Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39: 133-144, 2010.
19. Cheng H, Zhang L, Cogdell DE, Zheng H, Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W: Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6: e17745, 2011.